Yu-An Kung

543 total citations
13 papers, 386 citations indexed

About

Yu-An Kung is a scholar working on Infectious Diseases, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Yu-An Kung has authored 13 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 5 papers in Cardiology and Cardiovascular Medicine and 4 papers in Molecular Biology. Recurrent topics in Yu-An Kung's work include SARS-CoV-2 and COVID-19 Research (6 papers), Viral Infections and Immunology Research (5 papers) and SARS-CoV-2 detection and testing (4 papers). Yu-An Kung is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (6 papers), Viral Infections and Immunology Research (5 papers) and SARS-CoV-2 detection and testing (4 papers). Yu-An Kung collaborates with scholars based in Taiwan and United States. Yu-An Kung's co-authors include Shin‐Ru Shih, Chuan-Tien Hung, Kun‐Yi Chien, Jing‐Yi Lin, Kuo-Ming Lee, Yen‐Chin Liu, Sheng‐Yu Huang, Gary Brewer, Shih‐Tung Liu and Meiling Li and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Microbiology and Molecular Biology Reviews.

In The Last Decade

Yu-An Kung

12 papers receiving 384 citations

Peers

Yu-An Kung
Chuan-Tien Hung United States
Juili Lin-Goerke United States
N. Mehzabeen United States
Nicholas J. Palmer United States
Man Xing China
Chuan-Tien Hung United States
Yu-An Kung
Citations per year, relative to Yu-An Kung Yu-An Kung (= 1×) peers Chuan-Tien Hung

Countries citing papers authored by Yu-An Kung

Since Specialization
Citations

This map shows the geographic impact of Yu-An Kung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu-An Kung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu-An Kung more than expected).

Fields of papers citing papers by Yu-An Kung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu-An Kung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu-An Kung. The network helps show where Yu-An Kung may publish in the future.

Co-authorship network of co-authors of Yu-An Kung

This figure shows the co-authorship network connecting the top 25 collaborators of Yu-An Kung. A scholar is included among the top collaborators of Yu-An Kung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu-An Kung. Yu-An Kung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Lee, Hao-Yuan, et al.. (2025). Immunogenicity of second booster-dose COVID-19 mRNA vaccine among older adults in Taiwan. Biomedical Journal. 48(6). 100834–100834.
2.
Kung, Yu-An, Yi-Ching Chen, Chyi‐Liang Chen, et al.. (2024). Worldwide SARS-CoV-2 Omicron variant infection: Emerging sub-variants and future vaccination perspectives. Journal of the Formosan Medical Association. 124(7). 592–599. 3 indexed citations
3.
Palanisamy, Sathyadevi, Chih-Fei Kao, Wenliang Chen, et al.. (2023). One-step-one-pot hydrothermally derived metal-organic-framework-nanohybrids for integrated point-of-care diagnostics of SARS-CoV-2 viral antigen/pseudovirus utilizing electrochemical biosensor chip. Sensors and Actuators B Chemical. 390. 133960–133960. 14 indexed citations
4.
Kung, Yu-An, Jesse Davila‐Calderon, Le Luo, et al.. (2023). The 5′UTR of HCoV-OC43 adopts a topologically constrained structure to intrinsically repress translation. Journal of Biological Chemistry. 299(4). 103028–103028. 4 indexed citations
5.
Kung, Yu-An, et al.. (2022). Molecular Virology of SARS-CoV-2 and Related Coronaviruses. Microbiology and Molecular Biology Reviews. 86(2). e0002621–e0002621. 25 indexed citations
6.
7.
Kung, Yu-An, Sheng‐Yu Huang, Chung‐Guei Huang, et al.. (2022). Factors influencing neutralizing antibody titers elicited by coronavirus disease 2019 vaccines. Microbes and Infection. 25(1-2). 105044–105044. 7 indexed citations
8.
Huang, Sheng‐Yu, Yu-An Kung, Peng-Nien Huang, et al.. (2021). Stability of SARS-CoV-2 Spike G614 Variant Surpasses That of the D614 Variant after Cold Storage. mSphere. 6(2). 18 indexed citations
9.
Chen, Yi-Ching, Yu-An Kung, Rajendra Prasad Janapatla, et al.. (2021). Neutralization antibody titers against SARS-CoV-2 in an infant born to a mother with COVID-19. Pediatrics & Neonatology. 62(6). 661–663. 2 indexed citations
10.
Lin, Jing‐Yi, Yu-An Kung, & Shin‐Ru Shih. (2019). Antivirals and vaccines for Enterovirus A71. Journal of Biomedical Science. 26(1). 65–65. 70 indexed citations
11.
Kung, Yu-An, Chuan-Tien Hung, Kun‐Yi Chien, & Shin‐Ru Shih. (2016). Control of the negative IREStrans-acting factor KHSRP by ubiquitination. Nucleic Acids Research. 45(1). 271–287. 162 indexed citations
12.
Hung, Chuan-Tien, Yu-An Kung, Meiling Li, et al.. (2016). Additive Promotion of Viral Internal Ribosome Entry Site-Mediated Translation by Far Upstream Element-Binding Protein 1 and an Enterovirus 71-Induced Cleavage Product. PLoS Pathogens. 12(10). e1005959–e1005959. 36 indexed citations
13.
Kung, Yu-An, Chuan-Tien Hung, Yen‐Chin Liu, & Shin‐Ru Shih. (2014). Update on the development of enterovirus 71 vaccines. Expert Opinion on Biological Therapy. 14(10). 1455–1464. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026